Curium in Finland A legacy of excellence in nuclear medicine
Curium in Finland supports reliable access to nuclear medicine across Finland, Scandinavia and the Baltics through trusted local expertise and global capabilities.
Dedicated employees
Years' experience
Global customers
Countries
Manufacturing facilities
About Curium in Finland
For more than 20 years, Curium in Finland has supported healthcare providers with reliable radiopharmaceutical solutions, combining strong local expertise with the global capabilities of Curium.
Operating GMP-certified facilities in Helsinki and Tikkakoski, the company supports customers across more than 20 countries with a dedicated team of 80 employees committed to quality, reliability, and patient care.
A strong local foundation
Founded in 1991 as MAP Medical Technologies Oy, Curium in Finland has built a strong reputation for operational excellence and regulatory expertise. Since joining Curium in 2019, the company has further strengthened its ability to deliver high-quality radiopharmaceutical solutions across the region.
Reliable operations and supply
With three manufacturing facilities and wholesale distribution authorisation for medicinal products in Finland, Curium in Finland plays an important role in supporting consistent access to nuclear medicine throughout Scandinavia and the Baltics. Its operations are designed to ensure dependable supply, quality assurance, and efficient delivery to healthcare providers.
Connected to a global network
As part of Curium’s international organisation, Curium in Finland combines local knowledge with global scale, helping advance nuclear medicine through trusted partnerships, specialised expertise, and a shared commitment to improving patient care.
Curium products in Finland
Comprehensive radiopharmaceutical portfolio
Curium in Finland manufactures a growing portfolio of radiopharmaceutical solutions supporting both diagnostic imaging and targeted therapies.
Approved products include Pylclari and Fludeomap, while several innovative solutions are currently in development, including [18F] Sodium Fluoride (NaF) for injection, (18F) Fluorocholine chloride solution for injection, [177Lu] Lu-PSMA I&T solution for injection, and [225Ac] Actinium-PSMA I&T solution for injection.
Our Products page is unavailable
Details to our global products will be coming soon
Search Via Disease Areas
A World of Opportunities. Powered by Purpose.
Discover how your talent can thrive at Curium — where global purpose meets local impact, and every role helps shape the future of nuclear medicine.
Curium in Finland Locations
Finland
Country Headquarters
FI-00310 Helsinki
Finland
Helsinki (Kivihaka)
Sales Offices, Manufacturing Sites
Kivihaantie 7 F
FI-00310 Helsinki
Finland
Helsinki (Saukonpaasi)
Manufacturing Sites, PET Radiopharmacies
FI-00180 Helsinki
Finland
Tikkakoski
Sales Offices, Manufacturing Sites
FI-41160 Tikkakoski
Finland
Finland's Financial Contributions
2025
